)
Sohini Das writes on automobile and healthcare sectors for Business Standard. Over her 17 years as a journalist, she has covered multiple sectors and issues -- FMCG, dairy, tourism, and state elections, among others, across Kolkata, Ahmedabad, and Mumbai. She loves doing personality stories and ground reportage.
Sohini Das writes on automobile and healthcare sectors for Business Standard. Over her 17 years as a journalist, she has covered multiple sectors and issues -- FMCG, dairy, tourism, and state elections, among others, across Kolkata, Ahmedabad, and Mumbai. She loves doing personality stories and ground reportage.
Luxury carmaker to raise prices in two phases in 2025 due to forex pressures while expanding localisation to protect margins and banking on India's economic resilience
JLR had paused shipments to the US in April following US' declaration of a 25 per cent tariff on automobile imports
The auto-component industry which exports around $757 mn worth of parts to that country may benefit from the trade deal
Pharma industry veteran said that the US wanting to encourage local production is a very natural thing to do
India branded business grows 8% in Q4FY25 with 4 product launches while Ex-US markets rise 43% and US segment delivers 20% growth during the quarter
Despite the rise of GLP-1s and oral therapies, insulin remains vital for millions, particularly those with type 1 diabetes and other insulin-dependent conditions
Company plans greenfield PV plant by FY28 as SUV capacity runs past 90%
Zydus MD Sharvil Patel says the company is going beyond pharma into med-tech, diagnostics, and rare diseases, aiming for a global footprint while retaining India as the manufacturing hub
The overall Indian automotive market is moving towards premiumisation, a trend evident from the rising share of utility vehicles (UVs)
With outlay of ₹1,995 cr, state is targeting 30% EV registrations by 2030
M&M has entered into an agreement to acquire 58.96% in SML Isuzu for Rs 555 crore
The US already contributes a significant share, around a quarter, of Cipla's total revenues
Pharma major evaluating opportunities to out-license key cancer asset ISB-2001, deal likely in H1CY25
DTAB has accepted sub-panel recommendation on OTC drugs list
Sets price band of Rs 304-321 per share for IPO which opens on April 28
Hemant Sikka to head Mahindra Logistics, Veejay Nakra to head farm biz, R Veluswamy to head auto division
Kylaq success fuels confidence as carmaker eyes exports, higher India mkt share
Nuvama Institutional Equities said therapies like antidiabetic, anti-infective and respiratory had underperformed in the Indian pharma market
Most segments clock growth, commercial vehicle numbers decline: SIAM
Want govt to enforce anti-dumping duties, warn of mill closures and job losses